Infective endocarditis (IE) is among the most fatal infectious diseases. Since the introduction of various intracardiac devices and interventions, the clinical aspects of IE have rapidly evolved. In this paper, we aim to define the contemporary characteristics of patients diagnosed with definite IE and to identify the predictors associated with mortality. Through retrospective analysis of patients with TEE proven vegetation, those fulfilling the modified Duke criteria for definite IE were identified. Patient characteristics in relation to clinical outcomes and mortality were analyzed. Out of 50 patients (mean age 57±15.9 years, 34% female), 72% was native-valve endocarditis of which only 32% had a predisposing valve disease such as rheumati...
BACKGROUND: Embolic events are a major cause of morbidity and mortality in patients with infectiv...
Abstract Background: Infective endocarditis (IE) is associated with severe complications and high m...
Background—Surgical indications to prevent systemic embolism in infective endocarditis (IE) remain c...
IntroductionEmbolic events (EE) are a common complication during infective endocarditis (IE) and are...
International audienceThere has been an overall improvement in surgical mortality for patients with ...
Background—The incidence of embolic events (EE) and death is still high in patients with infective e...
Infective endocarditis (IE) is a life-threatening disease. Cerebral embolization complicates the cou...
Background: Nowadays, infective endocarditis (IE) is still burdened by a high mortality. In the abse...
AbstractDespite advances in therapy, infective endocarditis (IE) remains a serious disease with high...
Despite advances in therapy, infective endocarditis (IE) remains a serious disease with high mortali...
The clinical features and microbiological characteristics of 315 patients with definite or possible ...
Cerebral embolism due to infective endocarditis (IE) is associated with significant morbidity and mo...
International audienceInfective endocarditis (IE) remains severe. Few predictors of prognosis have b...
Background: Embolic events are a major cause of morbidity and mortality in patients with infective e...
Background: Diagnosis of infective endocarditis (IE) often is challenging, and mortality is high in...
BACKGROUND: Embolic events are a major cause of morbidity and mortality in patients with infectiv...
Abstract Background: Infective endocarditis (IE) is associated with severe complications and high m...
Background—Surgical indications to prevent systemic embolism in infective endocarditis (IE) remain c...
IntroductionEmbolic events (EE) are a common complication during infective endocarditis (IE) and are...
International audienceThere has been an overall improvement in surgical mortality for patients with ...
Background—The incidence of embolic events (EE) and death is still high in patients with infective e...
Infective endocarditis (IE) is a life-threatening disease. Cerebral embolization complicates the cou...
Background: Nowadays, infective endocarditis (IE) is still burdened by a high mortality. In the abse...
AbstractDespite advances in therapy, infective endocarditis (IE) remains a serious disease with high...
Despite advances in therapy, infective endocarditis (IE) remains a serious disease with high mortali...
The clinical features and microbiological characteristics of 315 patients with definite or possible ...
Cerebral embolism due to infective endocarditis (IE) is associated with significant morbidity and mo...
International audienceInfective endocarditis (IE) remains severe. Few predictors of prognosis have b...
Background: Embolic events are a major cause of morbidity and mortality in patients with infective e...
Background: Diagnosis of infective endocarditis (IE) often is challenging, and mortality is high in...
BACKGROUND: Embolic events are a major cause of morbidity and mortality in patients with infectiv...
Abstract Background: Infective endocarditis (IE) is associated with severe complications and high m...
Background—Surgical indications to prevent systemic embolism in infective endocarditis (IE) remain c...